Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score48

United States Fiscal year ends December CIK 0001787306 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

17 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Masaru Matsuda

EVP, Chief Legal Officer

—

$1.41M (2) scheduled

−$1.41M

111,289

0.0885%

$3.82M

−39.8%

Todd Watanabe

See Remarks

—

$139.47K (1)

−$139.47K

920,550

0.7324%

$31.59M

−5.9%

Howard G. Welgus

Director

—

$127.33K (1) scheduled

−$127.33K

35,207

0.0280%

$1.21M

−79.5%

Patrick Burnett

EVP, Chief Medical Officer

—

$30.05K (1)

−$30.05K

116,649

0.0928%

$4.00M

−40.5%

Bhaskar Chaudhuri

Director

—

—

—

867,826

0.6904%

$29.78M

+0.9%

David Joseph Topper

Chief Financial Officer

—

—

—

182,774

0.1454%

$6.27M

+15.4%

Larry Todd Edwards

See Remarks

—

—

—

175,178

0.1394%

$6.01M

+26.9%

Latha Vairavan

SVP Chief Financial Officer

—

—

—

85,978

0.0684%

$2.95M

+90.6%

Patrick J Heron

Director

—

—

—

59,661

0.0475%

$2.05M

+216.9%

Keith R Leonard

Director

—

—

—

27,901

0.0222%

$957.47K

+48.2%

Halley E Gilbert

Director

—

—

—

27,901

0.0222%

$957.47K

+48.2%

Neha Krishnamohan

Director

—

—

—

27,901

0.0222%

$957.47K

+77.2%

Sue-Jean Lin

Director

—

—

—

27,567

0.0219%

$946.01K

+44.1%

Terrie Curran

Director

—

—

—

23,526

0.0187%

$807.34K

+25.0%

Amit Munshi

Director

—

—

—

9,799

0.0078%

$336.27K

+390.0%

Christopher Peetz

Director

—

—

—

4,315

0.0034%

$148.08K

—

Robert A Scott

Director

—

—

—

2,819

0.0022%

$96.74K

—